Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Support

This activity is supported by an educational grant from Daiichi Sankyo, Inc.

Enduring CME Activity From the June 22, 2020, Live Webcast: COVID-19 and Cancer Care: What Oncologists Need to Know Today: Focus on Managing Patients with Hematologic Malignancies

Release Date: June 25, 2020
Expiration Date: June 25, 2021

Activity Overview

The novel coronavirus that causes coronavirus disease 2019 (COVID-19) has rapidly become one of the most challenging public health crises in modern history. With millions of confirmed infections worldwide, including over 2 million cases in the United States (as of June 23, 2020), this virus has the potential to infect individuals of all ages.

However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be the most vulnerable to infection and to developing more severe illness. Patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what do clinicians need to know today to ensure they are providing the best care to their patients with cancer?

This enduring CME activity is an archive of the live broadcast from June 22, 2020, featuring 4 hematologists who addressed the rapidly evolving issues clinicians face when treating patients with hematologic malignancies.

Acknowledgement of Support

This activity is supported by an educational grant from Daiichi Sankyo, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This online educational activity is directed toward hematologists, oncologists, infectious disease specialists, primary care physicians, nurses, pharmacists, nurse practitioners, physician assistants, and other health care professionals involved in the care of patients with cancer.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Discuss the risk of infection with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the severity of illness with COVID-19 across the populations of patients with hematologic malignancies
  • Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
  • Assess strategies to optimize treatment protocols for patients with hematologic malignancies in light of the current COVID-19 pandemic

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Ruben A. Mesa, MD, FACP
Ruben A. Mesa, MD, FACP
Director and Professor of Medicine
Mays Family Foundation Distinguished University Presidential Chair
Mays Cancer Center
San Antonio, TX

Disclosures: Grant/Research Support: Celgene, Incyte Corporation, AbbVie, Samus Therapeutics, Genotech Pharma, Promedior, CTI BioPharma; Consultant: Novartis, Sierra Oncology, and La Jolla Pharmaceutical Company.


Andre H. Goy, MD
Andre H. Goy, MD
Physician in Chief
Hackensack Meridian Health Oncology Care Transformation Service
Chairman & Chief Physician Officer
John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman, Oncology
Hackensack Meridian School of Medicine at Seton Hall University
Hackensack, NJ
Professor of Medicine
Georgetown University
Washington, DC

Disclosures: Grant/Research Support: Acerta Pharma, Celgene Corporation, Constellation Pharmaceuticals, Hackensack University Medical Center, F. Hoffmann-La Roche, Infinity Pharmaceuticals, Janssen Pharmaceuticals, Karyopharm Therapeutics, Kite Pharma/Gilead Sciences; Consultant: Acerta Pharma, Celgene Corporation, Physicians’ Education Resource®, LLC, Xcenda/AmerisourceBergen Corporation; Stock/Shareholder: COTA; Other Support: Physicians’ Education Resource®, LLC (travel expenses).

Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP
Professor and Chair, Department of Hematology and Medical Oncology
Emory University School of Medicine
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, GA

Disclosures: Grant/Research Support: Takeda Pharmaceutical Company, Janssen Pharmaceuticals, Celgene Corporation; Consultant: Takeda Pharmaceutical Company, Janssen Pharmaceuticals, Celgene Corporation, Novartis, Bristol Myers Squibb, Amgen, GlaxoSmithKline.

Gail J. Roboz, MD
Gail J. Roboz, MD
Director, Clinical and Translational Leukemia Program
Department of Hematology
Professor of Medicine
Weill Cornell Medical College of Cornell University
Attending Physician, New York Presbyterian Hospital
New York, NY

Disclosures: Consultancy or Advisory Board or Data and Safety Monitoring Committee: AbbVie, Actinium Pharmaceuticals, Agios Pharmaceuticals, Amphivena Therapeutics, Argenx, Array BioPharma, Astex, Astellas Pharma, Bayer, Celgene, Celltrion, Daiichi Sankyo, Eisai, Epizyme, Helsinn Healthcare, Janssen Pharmaceuticals, Jazz Pharmaceuticals, MEI Pharma (independent data monitoring committee chair), Novartis, Orsenix, Otsuka Pharmaceutical, Pfizer, Roche/Genentech, Sandoz, Takeda Pharmaceutical Company (independent review committee chair), Cardiff Oncology (formerly Trovagene); Research Support: Cellectis.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By